ChrysalisBioTherapeutics, Inc. is a privately held biopharmaceutical company developing regenerative drugs that mimic the body’s natural signals to activate endothelial progenitor cells and stem cells to stimulate tissue repair and restore normal tissue function.
Chrysalis BioTherapeutics , Inc.
Management
Technology
Deals/Partnering
Research Pipeline
Funding
BioStartup's Score
0 / 50
KEY DETAILS
Websitehttp://www.chrysbio.com
Founded2012
Disease Focus
Development Stage
STOCK CODENon Listed
Address2200 Market Street, STE 609 TX 77550GalvestonUnited States
2200 Market Street, STE 609 TX 77550
Galveston
United States
Contact Number+1 409 497 4083
+1 409 497 4083
[atom_linkedin linkedin_option=”CompanyInsider” linkedin_id=”https://www.linkedin.com/company/chrysalis-biotherapeutics” connections=”true” suffix=””]